Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Annals of Oncology
Published October 25, 2026
A randomised phase III trial of adjuvant treatment intensification with mFOLFIRINOX versus mFOLFO...
October 26, 2026
Medspoke
Medspoke
Annals of Oncology
Published October 25, 2026
00:00
--:--
Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Can...
October 26, 2026
Share
Clinical Complete Response with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer: First Results from the Global AZUR-1 Trial.
https://www.medspoke.co/channel_journal?id=785&tap_id=16321
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Clinical Colorectal Cancer
Published March 12, 2026
AZUR-4, a Phase 2, Open Label, Randomized Study of Neoadjuvant Dostarlimab Plus CAPEOX Versus CAP...
October 26, 2026
Why are you reporting this TALK?